Test homogeneity of risk difference across subgroups in clinical trials

Journal of Biopharmaceutical Statistics
Lanju ZhangIksung Cho

Abstract

A weighted least squares statistic is commonly used to test homogeneity of the risk difference for a series of 2 x 2 tables. Since the method is based on asymptotic theory, its type I error rate is inflated when the data are sparse. Two new methods for testing the homogeneity of risk difference across different groups in clinical trials are proposed in this paper. These methods are constructed, based on the Wilson's score test and traditional weighted least squares statistics. The performance of the new methods is evaluated and compared to the currently available approaches. Results show that one of our new methods has a type I error rate that is closest to the nominal level among all the methods and is much more powerful than those proposed by Lipsitz et al.

References

Jan 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M R CooperC Schiffer

❮ Previous
Next ❯

Citations

Feb 16, 2016·Pharmacoepidemiology and Drug Safety·A F SchmidtA W Hoes
Oct 9, 2019·Journal of Biopharmaceutical Statistics·Xu YanLilly Q Yue

❮ Previous
Next ❯

Software Mentioned

R

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.